Standard
Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment. / Willumsen, Nicholas; Bager, Cecilie Liv; Jensen, Christina; Karsdal, Morten Asser; Madsen, Daniel Hargbøl; Hansen, Morten; Schmidt, Henrik; Svane, Inge Marie.
In:
Journal of Clinical Oncology, Vol. 37, No. 15_suppl, e14050, 2019.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Willumsen, N, Bager, CL, Jensen, C, Karsdal, MA
, Madsen, DH, Hansen, M, Schmidt, H
& Svane, IM 2019, '
Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment.',
Journal of Clinical Oncology, vol. 37, no. 15_suppl, e14050.
https://doi.org/10.1200/JCO.2019.37.15_suppl.e14050APA
Willumsen, N., Bager, C. L., Jensen, C., Karsdal, M. A.
, Madsen, D. H., Hansen, M., Schmidt, H.
, & Svane, I. M. (2019).
Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment. Journal of Clinical Oncology,
37(15_suppl), [e14050].
https://doi.org/10.1200/JCO.2019.37.15_suppl.e14050Vancouver
Willumsen N, Bager CL, Jensen C, Karsdal MA
, Madsen DH, Hansen M et al.
Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment. Journal of Clinical Oncology. 2019;37(15_suppl). e14050.
https://doi.org/10.1200/JCO.2019.37.15_suppl.e14050Author
Willumsen, Nicholas ; Bager, Cecilie Liv ; Jensen, Christina ; Karsdal, Morten Asser ; Madsen, Daniel Hargbøl ; Hansen, Morten ; Schmidt, Henrik ; Svane, Inge Marie. / Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment. In: Journal of Clinical Oncology. 2019 ; Vol. 37, No. 15_suppl.
Bibtex
@article{928c010e94d54694b1dd9ce298a603fb,
title = "Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment.",
author = "Nicholas Willumsen and Bager, {Cecilie Liv} and Christina Jensen and Karsdal, {Morten Asser} and Madsen, {Daniel Hargb{\o}l} and Morten Hansen and Henrik Schmidt and Svane, {Inge Marie}",
year = "2019",
doi = "10.1200/JCO.2019.37.15_suppl.e14050",
language = "English",
volume = "37",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15_suppl",
}
RIS
TY - ABST
T1 - Assessment of extracellular matrix and tissue derived metabolites in a liquid biopsy for identifying endotypes of metastatic melanoma patients with differential response to immune checkpoint inhibitor treatment.
AU - Willumsen, Nicholas
AU - Bager, Cecilie Liv
AU - Jensen, Christina
AU - Karsdal, Morten Asser
AU - Madsen, Daniel Hargbøl
AU - Hansen, Morten
AU - Schmidt, Henrik
AU - Svane, Inge Marie
PY - 2019
Y1 - 2019
U2 - 10.1200/JCO.2019.37.15_suppl.e14050
DO - 10.1200/JCO.2019.37.15_suppl.e14050
M3 - Conference abstract in journal
VL - 37
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
SN - 0732-183X
IS - 15_suppl
M1 - e14050
ER -
